Browse > Article
http://dx.doi.org/10.4014/jmb.1905.05061

Generation of Full-Length Infectious cDNA Clones of Middle East Respiratory Syndrome Coronavirus  

Lee, Jeong Yoon (Korea Zoonosis Research Institute and Genetic Engineering Research Institute, Chonbuk National University)
Bae, Sojung (Korea Zoonosis Research Institute and Genetic Engineering Research Institute, Chonbuk National University)
Myoung, Jinjong (Korea Zoonosis Research Institute and Genetic Engineering Research Institute, Chonbuk National University)
Publication Information
Journal of Microbiology and Biotechnology / v.29, no.6, 2019 , pp. 999-1007 More about this Journal
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 and related infection cases have been reported in over 20 countries. Roughly 10,000 human cases have so far been reported in total with fatality rates at up to 40%. The majority of cases have occurred in Saudi Arabia with mostly sporadic outbreaks outside the country except for the one in South Korea in 2015. The Korean MERS-CoV strain was isolated from the second Korean patient and its genome was fully sequenced and deposited. To develop virus-specific protective and therapeutic agents against the Korean isolate and to investigate molecular determinants of virus-host interactions, it is of paramount importance to generate its full-length cDNA. Here we report that two full-length cDNAs from a Korean patient-isolated MERS-CoV strain were generated by a combination of conventional cloning techniques and efficient Gibson assembly reactions. The full-length cDNAs were validated by restriction analysis and their sequence was verified by Sanger method. The resulting cDNA was efficiently transcribed in vitro and the T7 promoter-driven expression was robust. The resulting reverse genetic system will add to the published list of MERS-CoV cDNAs and facilitate the development of Korean isolate-specific antiviral measures.
Keywords
MERS-CoV; full-length cDNA; reverse genetics;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Alexandersen S, Kobinger GP, Soule G, Wernery U. 2014. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound. Emerg. Dis. 61: 105-108.   DOI
2 Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, Azar SR, et al. 2016. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19: 891-900.   DOI
3 Tsetsarkin KA, Kenney H, Chen R, Liu G, Manukyan H, Whitehead SS, et al. 2016. A full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development. MBio 7.
4 Yang Y, Shan C, Zou J, Muruato AE, Bruno DN, de Almeida Medeiros Daniele B, et al. 2017. A cDNA clonelaunched platform for high-yield production of inactivated Zika vaccine. EBioMedicine 17: 145-156.   DOI
5 Zhang L, Ji W, Lyu S, Qiao L, Luo G. 2018. Tet-inducible production of infectious Zika virus from the full-length cDNA clones of african- and asian-lineage strains. Viruses 10.
6 Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, et al. 2003. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 100: 12995-13000.   DOI
7 Almazan F, Marquez-Jurado S, Nogales A, Enjuanes L. 2015. Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes. Methods Mol. Biol. 1282: 135-152.   DOI
8 Cockrell AS, Beall A, Yount B, Baric R. 2017. Efficient reverse genetic systems for rapid genetic manipulation of emergent and preemergent infectious coronaviruses. Methods Mol. Biol. 1602: 59-81.   DOI
9 Boehme KW, Ikizler M, Kobayashi T, Dermody TS. 2011. Reverse genetics for mammalian reovirus. Methods 55: 109-113.   DOI
10 Roner MR, Joklik WK. 2001. Reovirus reverse genetics: Incorporation of the CAT gene into the reovirus genome. Proc. Natl. Acad. Sci. USA 98: 8036-8041.   DOI
11 Ferguson NM, Van Kerkhove MD. 2014. Identification of MERS-CoV in dromedary camels. Lancet Infect. Dis. 14: 93-94.   DOI
12 Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, et al. 2014. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 14: 140-145.   DOI
13 Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367: 1814-1820.   DOI
14 Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. 2014. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 370: 2499-2505.   DOI
15 Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. 2017. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J. Hosp. Infect. 95: 207-213.   DOI
16 Ki M. 2015. 2015 MERS outbreak in Korea: hospital-tohospital transmission. Epidemiol. Health. 37: e2015033.   DOI
17 Kim SW, Park JW, Jung HD, Yang JS, Park YS, Lee C, et al. 2017. Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea. Clin. Infect. Dis. 64: 551-557.   DOI
18 Lim PL. 2015. Middle East respiratory syndrome (MERS) in Asia: lessons gleaned from the South Korean outbreak. Trans. R. Soc. Trop. Med. Hyg. 109: 541-542.   DOI
19 Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, et al. 2015. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 13: 210.   DOI
20 Fung IC, Tse ZT, Chan BS, Fu KW. 2015. Middle East respiratory syndrome in the Republic of Korea: transparency and communication are key. Western Pac. Surveill. Response J. 6: 1-2.   DOI
21 Ndung'u T, Renjifo B, Essex M. 2001. Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone. J. Virol. 75: 4964-4972.   DOI
22 de Wit E, Spronken MI, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res. 103: 155-161.   DOI
23 Jackson D, Cadman A, Zurcher T, Barclay WS. 2002. A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J. Virol. 76: 11744-11747.   DOI
24 Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD. 2006. Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc. Natl. Acad. Sci. USA 103: 4663-4668.   DOI
25 Prakash K, Hodinka RL, Hullihen DM, Plotkin SA. 1991. Isolation and characterization of an infectious molecular clone of the MN strain of HIV-1. Biochem. Biophys. Res. Commun. 179: 1377-1383.   DOI
26 Martinez-Sobrido L, de la Torre JC. 2016. Reporterexpressing, replicating-competent recombinant arenaviruses. Viruse 8.
27 Castrucci MR, Bilsel P, Kawaoka Y. 1992. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J. Virol. 66: 4647-4653.   DOI
28 Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, et al. 2009. Replication-deficient ebolavirus as a vaccine candidate. J. Virol. 83: 3810-3815.   DOI
29 Gibson DG. 2011. Enzymatic assembly of overlapping DNA fragments. Methods Enzymol. 498: 349-361.   DOI
30 Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, 3rd, Smith HO. 2009. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6: 343-345.   DOI
31 Jeon H, Kang YH, Yoo SM, Park MJ, Park JB, Lee SH, et al. 2018. Kaposi's sarcoma-associated herpesvirus infection modulates the proliferation of glioma stem-like cells. J. Microbiol. Biotechnol. 28: 165-174.   DOI
32 Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, et al. 1996. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann. Intern. Med. 124: 539-547.   DOI
33 Almazan F, DeDiego ML, Sola I, Zuniga S, Nieto-Torres JL, Marquez-Jurado S, et al. 2013. Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio. 4: e00650-00613.
34 Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, et al. 2013. Reverse genetics with a fulllength infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 110: 16157-16162.   DOI
35 Park BJ, Jung ST, Choi CS, Myoung J, Ahn HS, Han SH, et al. 2018. Pathogenesis of human norovirus genogroup II genotype 4 in post-weaning gnotobiotic pigs. J. Microbiol. Biotechnol. 28: 2133-2140.   DOI
36 Song M, Kim JS, Liu L, Husain M, Vazquez-Torres A. 2016. Antioxidant defense by thioredoxin can occur independently of canonical thiol-disulfide oxidoreductase enzymatic activity. Cell Rep. 14: 2901-2911.   DOI
37 Yoon SJ, Park YJ, Kim HJ, Jang J, Lee SJ, Koo S, et al. 2018. Optimized expression, purification, and rapid detection of recombinant influenza nucleoproteins expressed in Sf9 insect cells. J. Microbiol. Biotechnol. 28: 1683-1690.   DOI
38 Kang HS, Myoung J, So EY, Bahk YY, Kim BS. 2016. Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination. J. Neuroinflammation 13: 133.   DOI
39 Kang S, Choi C, Choi I, Han KN, Rho SW, Choi J, et al. 2018. Hepatitis E virus methyltransferase inhibits type i interferon induction by targeting RIG-I. J. Microbiol. Biotechnol. 28: 1554-1562.   DOI
40 Fernandez-Rodriguez J, Moser F, Song M, Voigt CA. 2017. Engineering RGB color vision into Escherichia coli. Nat. Chem. Biol. 13: 706-708.   DOI
41 Song M, Sukovich DJ, Ciccarelli L, Mayr J, Fernandez-Rodriguez J, Mirsky EA, et al. 2017. Control of type III protein secretion using a minimal genetic system. Nat. Commun. 8: 14737.   DOI
42 Dudek T, Knipe DM. 2006. Replication-defective viruses as vaccines and vaccine vectors. Virology 344: 230-239.   DOI
43 Giel-Moloney M, Rumyantsev AA, David F, Figueiredo M, Feilmeier B, Mebatsion T, et al. 2017. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector. Vaccine 35: 6898-6904.   DOI
44 Welch SK, Jolie R, Pearce DS, Koertje WD, Fuog E, Shields SL, et al. 2004. Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates. Vet. Immunol. Immunopathol. 102: 277-290.   DOI
45 Racaniello VR. 1984. Studying poliovirus with infectious cloned cDNA. Rev. Infect. Dis. 6 Suppl 2: S514-515.   DOI
46 Kang S, Myoung J. 2017. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J. Microbiol. 55: 319-329.   DOI
47 Kim E, Myoung J. 2018. Hepatitis E virus papain-like cysteine protease inhibits type i interferon induction by down-regulating melanoma differentiation-associated gene 5. J. Microbiol. Biotechnol. 28: 1908-1915.   DOI
48 Gholamalipour Y, Karunanayake Mudiyanselage A, Martin CT. 2018. 3' end additions by T7 RNA polymerase are RNA self-templated, distributive and diverse in character-RNASeq analyses. Nucleic Acids Res. 46: 9253-9263.   DOI
49 Stobart CC, Moore ML. 2014. RNA virus reverse genetics and vaccine design. Viruses 6: 2531-2550.   DOI
50 Racaniello VR, Baltimore D. 1981. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214: 916-919.   DOI
51 Matsui SM, Kim JP, Greenberg HB, Su W, Sun Q, Johnson PC, et al. 1991. The isolation and characterization of a Norwalk virus-specific cDNA. J. Clin. Invest. 87: 1456-1461.   DOI
52 Katayama K, Murakami K, Sharp TM, Guix S, Oka T, Takai-Todaka R, et al. 2014. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc. Natl. Acad. Sci. USA 111: E4043-4052.   DOI
53 Kang S, Myoung J. 2017. Host innate immunity against hepatitis E virus and viral evasion mechanisms. J. Microbiol. Biotechnol. 27: 1727-1735.   DOI
54 Panda SK, Ansari IH, Durgapal H, Agrawal S, Jameel S. 2000. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J. Virol. 74: 2430-2437.   DOI